Comparative study between Sodium hyaluronic acid and dextrose prolotherapy in management of Temporo-mandibular joint internal derangement.

Abstract

Aim: The study was done to compare between hyaluronic acid and dextrose prolotherapy in management of temporomandibular joint internal derangement. Patients and methods: The present study included 30 adult patients suffering from internal derangement of Temporo-mandibular joint were selected from outpatient clinic, oral and maxillofacial surgery department in faculty of dentistry, Suez Canal University as well as October 6 university. Group I: Composed of 15 patients (10 females, 5 males) where hyaluronic acid was injected intra-articular. Group II: Composed of 15 patients (9 females, 6 males) where dextrose prolotherapy was injected (4 times) at 2 weeks, 4 weeks and 6 weeks intervals over a total of 12 weeks. Results: No difference between Group I and II; both showed the highest mean MIO values. Group I and Group II; both showed lower mean of VAS scores after 12 months compared to pre-operative measurement. After 6 months, Group II showed the highest prevalence of deviation followed by Group I. Conclusion: Sodium hyaluronic acid and Prolotherapy is a successful technique to improve maximum inter-incisal opening as well as assisted interincisal opening and improved higher significant changes in pain intensity. INTRODUCTION Internal derangements of TMJ were nonsurgical treated in initial stages with medications, physiotherapy and occlusal splints (1). Intra articular injection of corticosteroids alone or after arthrocentesis provides long-term palliative effects on clinical signs and subjective symptoms of TMJ pain (2,3). Various studies have demonstrated the use of drugs, others recommended Corticosteroids, dextrose prolotherapy and SH for treatment of TMD’s(4,5). Aim of study: was done to compare between hyaluronic acid and dextrose prolotherapy in management of temporomandibular joint internal derangement. DOI: 10.21608/dsu.2021.24268.1029 Manuscript ID: DSU-2002-1029